Estibaliz Capetillo González de Zarate
Principal Investigator
Research groups:
Contact
Correo electrónico:Estibaliz.Capetillo@ehu.eus
Tel.:(+34) 94 601 8159
Science Park of the UPV/EHU
Sede Building, 3rd floor, Barrio Sarriena, s/n
E-48940 Leioa Spain
About me
Publications
-
A nonlinear meccano for Alzheimer's emergence by amyloid β-mediated glutamatergic hyperactivity
Neurobiology of Disease (May, 2024) DOI: 10.1016/j.nbd.2024.106473 -
Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer’s Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms
International Journal of Molecular Sciences (Apr, 2024) DOI: 10.3390/ijms25094594 -
Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy
Autophagy (Jan, 2023) DOI: 10.1080/15548627.2023.2165313 -
New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's Disease
International journal of molecular sciences (Aug, 2022) DOI: 10.3390/ijms23169256 -
Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies
Autophagy (Jul, 2022) DOI: 10.1080/15548627.2022.2095791 -
Linking Plasma Amyloid Beta and Neurofilament Light Chain to Intracortical Myelin Content in Cognitively Normal Older Adults
Frontiers in Aging Neuroscience (Jun, 2022) DOI: 10.3389/fnagi.2022.896848 -
Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography
Alzheimer's Research & Therapy (Jun, 2022) DOI: 10.1186/s13195-022-01016-5 -
Recombinant Integrin β1 Signal Peptide Blocks Gliosis Induced by Aβ Oligomers
International Journal of Molecular Sciences (May, 2022) DOI: 10.3390/ijms23105747 -
A Neuron, Microglia, and Astrocyte Triple Co-culture Model to Study Alzheimer’s Disease
Frontiers in Aging Neuroscience (Apr, 2022) DOI: 10.3389/fnagi.2022.844534 -
Amyloid β / PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer´s disease
Cell Death & Disease (Mar, 2022) DOI: 10.1038/s41419-022-04687-y